ANALYSIS OF HBsAg ISOFORMS DURING AND AFTER NAP-BASED COMBINATION THERAPY IN THE REP 301, REP 301-LTF AND REP 401 STUDIES

Bazinet, M; Anderson, M; Pantea, V; Placinta, G; Moscalu, I; Cebotarescu, V; Cojuhari, L; Jimbei, P; Iarovoi, L; Smesnoi, V; Musteata, T; Jucov, A; Gersch, J; Holzmayer, V; Kuhns, M; Cloherty, G; Vaillant, A

HEPATOLOGY, 2020; 72 (): 500A